Literature DB >> 23991309

A 4-year surveillance of antimicrobial resistance patterns of Acinetobacter baumanni in a university-affiliated hospital in China.

Ting Xu1, Wenying Xia, Guodong Rong, Shiyang Pan, Peijun Huang, Bing Gu.   

Abstract

OBJECTIVES: To investigate the changes in resistance of Acinetobacter baumanni (A. baumannii) to different antimicrobial agents and the association of resistance rates with several independent factors: specimen origin, hospital wards, patients' gender and age, from 2008 to 2011.
METHODS: Bacterial isolates were isolated from January 2008 to December 2011 in the First Affiliated Hospital of Nanjing Medical University. Antimicrobial susceptibility testing was determined by the Kirby-Bauer Disk Diffusion Agar method as recommended by CLSI. Data were managed by the software WHONET 5.4 and analyzed by SPSS 17.0 software.
RESULTS: The proportion of A. baumannii in our hospital increased from 7.0% in 2008 to 18.8% in 2011, becoming the most frequent pathogen in gram-negative isolates. 79.9% of A. baumannii were cultured from respiratory tract and geriatrics showed the highest isolation rate of A. baumannii during 4 years. The resistance rates to 12 antibiotics significantly increased from 2008 to 2011, from 14.8% to 90.8% to imipenem, and from 23.3% to 91.1% to meropenem. Statistical analysis demonstrated that the specimen origin, hospital wards, patients' gender and age were associated with resistance rate in varying degrees.
CONCLUSIONS: The 4-year surveillance of antimicrobial susceptibility demonstrated the rapid increase of drug-resistant strains of A. baumannii, and revealed several factors related with resistance rate. Knowing the antimicrobial resistance patterns will help guide the empirical therapy and strengthen interventional infection control measures in China.

Entities:  

Keywords:  Acinetobacter baumanni (A. baumannii); antibiotic resistance; carbapenem; nosocomial infection

Year:  2013        PMID: 23991309      PMCID: PMC3755656          DOI: 10.3978/j.issn.2072-1439.2013.08.36

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  22 in total

1.  Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.

Authors:  Qiaojuan Hu; Zhidong Hu; Jing Li; Bin Tian; Hairu Xu; Jin Li
Journal:  J Basic Microbiol       Date:  2011-03-24       Impact factor: 2.281

2.  Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.

Authors:  Young Kyoung Park; Sook-In Jung; Kyong-Hwa Park; Dae Hun Kim; Ji Young Choi; Su Hwan Kim; Kwan Soo Ko
Journal:  J Med Microbiol       Date:  2011-08-18       Impact factor: 2.472

Review 3.  Drug treatment for multidrug-resistant Acinetobacter baumannii infections.

Authors:  Matteo Bassetti; Elda Righi; Silvano Esposito; Nicola Petrosillo; Laura Nicolini
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

4.  Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.

Authors:  Maria Cristina Bronharo Tognim; Soraya Sgambatti Andrade; Suzane Silbert; Ana Cristina Gales; Ronald N Jones; Hélio S Sader
Journal:  Int J Infect Dis       Date:  2004-09       Impact factor: 3.623

5.  Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Authors:  Rebecca H Sunenshine; Marc-Oliver Wright; Lisa L Maragakis; Anthony D Harris; Xiaoyan Song; Joan Hebden; Sara E Cosgrove; Ashley Anderson; Jennifer Carnell; Daniel B Jernigan; David G Kleinbaum; Trish M Perl; Harold C Standiford; Arjun Srinivasan
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

Review 6.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

7.  Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002-2006.

Authors:  M Wadl; K Heckenbach; I Noll; S Ziesing; W Pfister; J Beer; S Schubert; T Eckmanns
Journal:  Infection       Date:  2010-01-27       Impact factor: 3.553

8.  Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.

Authors:  Hui Wang; Ping Guo; Hongli Sun; He Wang; Qiwen Yang; Minjun Chen; Yingchun Xu; Yuanjue Zhu
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

9.  Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit.

Authors:  Ji Ye Jung; Moo Suk Park; Song Ee Kim; Byung Hoon Park; Ji Young Son; Eun Young Kim; Joo Eun Lim; Sang Kook Lee; Sang Hoon Lee; Kyung Jong Lee; Young Ae Kang; Se Kyu Kim; Joon Chang; Young Sam Kim
Journal:  BMC Infect Dis       Date:  2010-07-30       Impact factor: 3.090

Review 10.  Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis; Ilias I Siempos
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more
  5 in total

1.  Population Pharmacokinetics and Dosing Optimization of Imipenem in Children with Hematological Malignancies.

Authors:  Lei Dong; Xiao-Ying Zhai; Yi-Lei Yang; Li Wang; Yue Zhou; Hai-Yan Shi; Bo-Hao Tang; Yue-E Wu; Fan Yang; Li Wen; Hong-Xiao Kong; Li-Juan Zhi; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  What is the role of empirical treatment for suspected invasive candidiasis in non-neutropenic non transplanted patients in the intensive care unit?-Empiricus strikes back!

Authors:  Cédric Bretonnière; Karim Lakhal; Thierry Lepoivre; David Boutoille; Florent Morio
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  Antibiotic resistance of non-fermenting Gram-negative bacilli isolated at a large Infectious Diseases Hospital in North-Eastern Romania, during an 11-year period.

Authors:  Elena Roxana Buzilă; Eduard Vasile Năstase; Cătălina Luncă; Aida Bădescu; Egidia Miftode; Luminiţa Smaranda Iancu
Journal:  Germs       Date:  2021-09-29

4.  An Investigation of Antibacterial Resistance Patterns Among Acinetobacter baumannii and Pseudomonas aeruginosa Isolates Collected from Intensive Care Units of a University-Affiliated Hospital in Ahvaz, Iran.

Authors:  Farrokh Izadpour; Nastaran Ranjbari; Mohammad-Reza Aramesh; Mojtaba Moosavian; Shiva ShahAli; Farzaneh Larki; Hamed Tabesh; Afrooz Morvaridi
Journal:  Jundishapur J Microbiol       Date:  2016-08-16       Impact factor: 0.747

5.  Genetic characterization and in vitro activity of antimicrobial combinations of multidrug-resistant Acinetobacter baumannii from a general hospital in China.

Authors:  Fang Chen; Ling Wang; Min Wang; Yixin Xie; Xiaomeng Xia; Xianping Li; Yanhua Liu; Wei Cao; Tingting Zhang; Pengling Li; Min Yang
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.